Madeleine Löfstrand
-
Development of Hillchol (R), a low-cost inactivated single strain Hikojima oral cholera
vaccine
T. Sharma, N. Joshi, A. K. Mandyal, Stefan Nordqvist, Michael Lebens, V. Kanchan, Madeleine Löfstrand, Frida Jeverstam, M. M. Ahasan, I. Khan, M. Karim, H. Muktadir, A. Muktadir, D. Gill, Jan Holmgren
Vaccine - 2020-01-01 -
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2
trial
F. Qadri, M. Akhtar, T. R. Bhuiyan, M. I. Chowdhury, T. Ahmed, T. A. Rafique, A. Khan, S. I. A. Rahman, F. Khanam, Anna Lundgren, Gudrun Wiklund, Joanna Kaim, Madeleine Löfstrand, N. Carlin, A. L. Bourgeois, N. Maier, A. Fix, T. Wierzba, R. I. Walker, Ann-Mari Svennerholm
Lancet Infectious Diseases - 2020-01-01 -
Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine
ETVAX
Susannah Leach, Anna Lundgren, N. Carlin, Madeleine Löfstrand, Ann-Mari Svennerholm
Vaccine - 2017-01-01